oxymorphone and oxycodone.

15. On November 28, 2016, Board staff interviewed the Respondent, who
appeared approximately two hours late for the interview. The Respondent claimed that
she was delayed because she had filed a police report for a break-in at her home the
previous night and that she had been "attacked." Board staff questioned the
Respondent about her delay in appearing for her toxicology screening. The
Respondent provided a series of explanations that included being unable to find the
person who drove her to the Board, stopping to eat, losing the directions to the
laboratory, and getting lost.

16. Board staff questioned the Respondent about whether her toxicology
screening would come back positive for any substances. The Respondent initially
replied no, but then stated that depending on how sensitive the hair test she underwent
was, she may test positive for Fentanyl, claiming that she had used a prescribed patch
for knee pain. The Respondent also stated that she did take "a couple of oxycodones"
too.

17. | The Respondent stated that although her medical office was in Delaware,
she also provided medical care and treatment to patients at her Maryland residence.
The Respondent cited one instance in which an individual stopped by her residence
because he "needed his prescription changed." Board investigation noted other
evidence that the Respondent practiced medicine in Maryland, including reports that
she kept patient files in her residence and personal vehicle. In addition, pharmacy
surveys indicate that the Respondent prescribed extensive amounts of CDS and

prescription medications in Maryland. The Respondent also admitted to police that she
